These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 2441217)
41. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan. Kataoka T; Sakurai Y; Ida N; Kobayashi S Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536 [No Abstract] [Full Text] [Related]
42. [Recent findings in the field of oncological therapy with interferon]. Pugliese A; Vitale M; Cosseta P G Batteriol Virol Immunol; 1981; 74(7-12):308-19. PubMed ID: 6182049 [No Abstract] [Full Text] [Related]
43. A prospective randomized trial of alpha 2B-interferon/gamma-interferon or the combination in advanced metastatic renal cell carcinoma. Foon K; Doroshow J; Bonnem E; Fefer A; Graham S; Grosh B; Narayan P; Elias L; Harvey H; Schulof R J Biol Response Mod; 1988 Dec; 7(6):540-5. PubMed ID: 3145964 [TBL] [Abstract][Full Text] [Related]
51. Advances of immunotherapy of cancer: monoclonal antibodies and interferon. Foon KA Semin Oncol Nurs; 1988 May; 4(2):112-9. PubMed ID: 3131862 [No Abstract] [Full Text] [Related]
52. Treatment of multiple sclerosis with various interferons: the cons. Johnson KP Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576 [TBL] [Abstract][Full Text] [Related]
53. The clinical implications of human interferon. Cesario TC Med Clin North Am; 1983 Sep; 67(5):1147-62. PubMed ID: 6413792 [No Abstract] [Full Text] [Related]
54. The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice. Twentyman PR; Workman P; Wright KA; Bleehen NM Br J Cancer; 1985 Jul; 52(1):21-9. PubMed ID: 3925974 [TBL] [Abstract][Full Text] [Related]
55. Type I interferon resistance in a colorectal cancer cell line is associated with a more aggressive phenotype in vivo. Toth CA; Thomas P Br J Cancer; 1992 Mar; 65(3):365-8. PubMed ID: 1558789 [TBL] [Abstract][Full Text] [Related]
56. [Roferon-A. Canferon-A. Interferon alpha-2A (genetic recombination)]. Taguchi T Gan To Kagaku Ryoho; 1988 Jan; 15(1):171-6. PubMed ID: 3337525 [No Abstract] [Full Text] [Related]
57. The in vitro interaction of RA-233 and several interferons on human cell lines. Wolf LM; Leitzel KE; Harvey HA; Lipton A J Med; 1984; 15(1):15-21. PubMed ID: 6436421 [TBL] [Abstract][Full Text] [Related]
58. [Antitumor effect of interferons]. Ebina T; Saito M Gan To Kagaku Ryoho; 1984 Jan; 11(1):24-35. PubMed ID: 6421241 [TBL] [Abstract][Full Text] [Related]
59. Human interferon as a therapeutic agent--current status. Merigan TC N Engl J Med; 1983 Jun; 308(25):1530-1. PubMed ID: 6190083 [No Abstract] [Full Text] [Related]
60. [Interferon: facts and hopes. I. Properties of interferon]. Dmoszyńska-Giannopoulou A; Rupniewska ZM Pol Arch Med Wewn; 1981 Oct; 66(4):303-6. PubMed ID: 6174953 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]